L&K Biomed Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	3,178	3,835	5,047	7,395	16,108
Short-Term Investments	3,108	16,108	7,729	5,608	3,108
Cash & Short-Term Investments	6,286	19,943	12,776	13,003	19,216
Cash Growth	-68.48%	56.10%	-1.75%	-32.33%	133.88%
Accounts Receivable	17,912	14,980	9,839	5,780	1,526
Other Receivables	739.65	290.26	1,066	223.05	635.92
Receivables	18,933	16,015	10,905	6,003	2,162
Inventory	34,658	24,551	19,089	16,366	13,856
Prepaid Expenses	680.38	525.95	656.55	444.63	688.1
Other Current Assets	612.06	2,532	990.85	330.62	2,042
Total Current Assets	61,170	63,566	44,417	36,147	37,964
Property, Plant & Equipment	9,617	10,005	9,012	8,514	9,271
Long-Term Investments	644.53	577.5	1,049	64.15	1,203
Other Intangible Assets	1,059	998.17	798.73	715.11	1,209
Long-Term Accounts Receivable	4,140	1,807	1,281	2,385	5,200
Long-Term Deferred Tax Assets	5,277	5,009	5,516	3,902	3,591
Long-Term Deferred Charges	-	-	-	106.09	223.63
Other Long-Term Assets	1,375	798.55	387.38	829.96	623.29
Total Assets	83,483	83,061	62,762	52,663	59,285
Accounts Payable	3,781	3,347	2,047	2,437	498.73
Accrued Expenses	963.43	851.44	685.87	589.86	606.95
Short-Term Debt	15,279	20,558	10,040	20,406	6,692
Current Portion of Long-Term Debt	1,100	800	100	2,800	-
Current Portion of Leases	706.84	669.07	828.69	750.57	636.63
Current Income Taxes Payable	205.08	7.29	0.35	54.09	0.89
Other Current Liabilities	16,296	12,841	9,062	10,943	4,177
Total Current Liabilities	38,332	39,074	22,763	37,981	12,613
Long-Term Debt	500	1,000	1,700	-	13,608
Long-Term Leases	1,562	369.63	845.16	1,244	1,518
Pension & Post-Retirement Benefits	3,119	3,057	2,232	1,574	1,330
Long-Term Deferred Tax Liabilities	1,216	1,569	1,361	1,047	-
Other Long-Term Liabilities	118.91	1,958	3,274	55.37	5,429
Total Liabilities	44,848	47,028	32,175	41,902	34,499
Common Stock	10,893	9,968	9,968	6,703	6,696
Additional Paid-In Capital	73,692	90,386	90,386	68,174	67,992
Retained Earnings	-40,867	-58,746	-67,849	-65,348	-51,884
Treasury Stock	-0.09	-0.09	-0.09	-0.09	-0.09
Comprehensive Income & Other	1,759	887.93	2,846	2,740	1,663
Total Common Equity	45,477	42,496	35,351	12,268	24,467
Minority Interest	-6,842	-6,463	-4,764	-1,507	319.82
Shareholders' Equity	38,635	36,033	30,587	10,762	24,787
Total Liabilities & Equity	83,483	83,061	62,762	52,663	59,285
Total Debt	19,148	23,397	13,513	25,201	22,456
Net Cash (Debt)	-12,861	-3,454	-737.76	-12,198	-3,240
Net Cash Per Share	-632.94	-158.80	-45.50	-910.57	-242.05
Filing Date Shares Outstanding	21.15	19.94	19.94	13.41	13.39
Total Common Shares Outstanding	21.15	19.94	19.94	13.41	13.39
Working Capital	22,838	24,492	21,654	-1,834	25,351
Book Value Per Share	2149.90	2131.56	1773.17	915.17	1826.89
Tangible Book Value	44,418	41,498	34,553	11,553	23,258
Tangible Book Value Per Share	2099.84	2081.50	1733.11	861.82	1736.61
Land	737.02	737.02	737.02	737.02	737.02
Buildings	2,502	2,502	2,502	2,502	2,502
Machinery	16,006	16,491	14,307	12,330	11,671
Construction In Progress	25	59	-	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.